Delivery Order SPE2DB22D2206-SPE2DB25FKA50
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,876.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units), a prescription medication used in weight management treatment. The contract, which was competitively awarded with no set-aside designation, was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, utilizing...
- The Defense Logistics Agency awarded a $1,013.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 31, 2025, and performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $1,642.44 worth of Qsymia 11.25mg-69mg tablets (30-count) under a firm fixed-price contract. The award was made competitively without set-aside restrictions and is scheduled for completion by September 13, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. This delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for $1,225.31 on June 5, 2025, for the supply of Qsymia 3.75 mg-23 mg capsules (30-count package). This is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,547.92 delivery order to AmerisourceBergen Drug Corp for QSYMIA 7.5 MG-46 MG capsules (30-count units), a pharmaceutical product used in weight management treatment. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $4,444.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 15 mg–92 mg capsules (30-count) on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price delivery order utilizes no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the contractor's location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a $1,945.44 firm fixed-price delivery order for QSYMIA 11.25 mg-69 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The product...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 30 capsules of Qsymia 3.75 mg-23 mg, a prescription medication used for weight management. This firm fixed-price delivery order, valued at $1,580.64, was awarded on September 22, 2025, with an ultimate completion date of September 23, 2025. The contract is non-set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,922.80 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Qsymia 3.75 mg-23 mg capsules in a 30-count package. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and no set-aside designation was utilized. The award represents a competitive procurement action through an open competition process. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $256.72 to Amerisourcebergen Drug Corporation for the supply of Qsymia 3.75 MG-23 MG capsules. Under this single award, Amerisourcebergen will deliver 30 capsules to a location in Conshohocken, Pennsylvania within a one day period of performance from September 21 through September 22, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for an anti-obesity...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKA50Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,071.43 to AmerisourceBergen Drug Corp for Qsymia 3.75 mg-23 mg capsules (30-count units), with performance in Conshohocken, Pennsylvania and completion by September 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement and holds significant contracts with the Defense Logistics Agency's Medical Supply Chain. The company serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, delivering brand-name and generic medications, vaccines, and specialized medical supplies through competitively awarded contracts with firm fixed pricing. This delivery order for Qsymia, a prescription medication used in weight management, exemplifies the company's role as a primary supplier of specialized pharmaceuticals to support military and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/22/25 |